Results 41 to 50 of about 19,354 (307)
Objectives: The Carpentier-Edwards Perimount Magna Ease (Edwards Lifesciences) pericardial bioprosthesis has demonstrated satisfying hemodynamics at midterm follow-up, but its durability remains unclear.
Stéphane Kermen, MD +6 more
doaj +1 more source
Interdisciplinary three-step strategy to treat aortic stenosis and coronary artery disease in a patient with end-stage chronic obstructive pulmonary disease [PDF]
Background: Valvular aortic stenosis is a common disease in the elderly, often in multimorbid patients. It is often associated with coronary artery disease and peripheral artery disease.
Beiras Fernández, Andrés +6 more
core +2 more sources
Minimally invasive aortic valve replacement (mini‐AVR) might improve clinical outcomes, particularly in high‐risk and elderly patients. Sutureless/rapid deployment bioprosthesis can offer advantage of decreasing the cross‐clamp time (XCT) and easing the ...
D. Sef, Martina Krajnc, T. Klokocovnik
semanticscholar +1 more source
OBJETIVO: Avaliar a descelularização com SDS como tratamento anticalcificante em pericárdio bovino fixado em glutaraldeído. MÉTODOS: Peças de 0,5 cm² foram implantadas em modelo subcutâneo de 18 ratos por até 90 dias.
Claudinei Collatusso +5 more
doaj +1 more source
Presence Of A Congenitally Bicuspid Aortic Valve Among Patients Having Combined Mitral And Aortic Valve Replacement [PDF]
Although bicuspid aortic valve occurs in an estimated 1% of adults and mitral valve prolapse in an estimated 5% of adults, occurrence of the 2 in the same patient is infrequent.
Hamman, Baron Lloyd +5 more
core +1 more source
Prosthetic Aortic Valves: Challenges and Solutions
Aortic Valve Disease (AVD) is the most common Valvular Heart Disease (VHD), affecting millions of people worldwide. Severe AVD is treated in most cases with prosthetic aortic valve replacement, which involves the substitution of the native aortic valve ...
Lucia Musumeci +7 more
doaj +1 more source
SOURCE 3 Registry Design and 30-Day Results of the European Postapproval Registry of the Latest Generation of the SAPIEN 3 Transcatheter Heart Valve [PDF]
BACKGROUND: The SOURCE 3 Registry (SAPIEN Aortic Bioprosthesis European Outcome) is a European multicenter, observational registry of the latest generation of transcatheter heart valve, the SAPIEN 3 (Edwards Lifesciences, Irvine, CA).
Baumgartner, Helmut +9 more
core +1 more source
Objectives: Although bioprosthetic valves have excellent hemodynamic properties and can eliminate the need for lifelong anticoagulation therapy, these devices are associated with high rates of reoperation and limited durability.
Pearly K. Pandya, BS +3 more
doaj +1 more source
Comparison between three types of stented pericardial aortic valves (Trivalve trial): study protocol for a randomized controlled trial [PDF]
International audienceBackgroundAortic valve stenosis is one of the most common heart diseases in older patients. Nowadays, surgical aortic valve replacement is the 'gold standard' treatment for this pathology and the most implanted prostheses are ...
Azarnoush, Kasra +9 more
core +4 more sources
Early surgical aortic bioprosthesis failure caused by cusp tear: A word of caution
Cusp tear is an increasingly described mode of failure of the Trifecta aortic bioprosthesis. Acute aortic regurgitation after implantation of a Trifecta in absence of endocarditis should suggest a cusp tear and be promptly treated with redo surgery.
Thibault Schaeffer +2 more
semanticscholar +1 more source

